Shifts at Pfizer

Pfizer is closing a research and development site in the UK at Sandwich, Kent, notes In the Pipeline's Derek Lowe. About 2,400 people work at the site and Pfizer says that it hopes to transfer a few those positions to other sites. "Although the company says that perhaps several hundred may find positions elsewhere, this is a major blow to drug discovery operations in the UK," Lowe says.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

US Attorney General Jeff Sessions is considering using DNA tests to determine relatedness between adult and child migrants, the Daily Caller reports.

Bloomberg reports that Brainstorm Cell Therapeutics plans to offer a treatment it is developing under the "right to try" law for hundreds of thousands of dollars.

In Nature this week: expansion of disease-resistance genes among long-lived oak trees, and more.

In a proof-of-concept study, researchers report being able to determine age from dried bloodstains, Discover's D-brief blog reports.